Latin America Poultry Vaccines Market: By Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines,Recombinant Vaccines), By Formulation (Dry Form (Duct) Vaccines,Liquid Vaccines,Freeze Dried Vaccines), By Application (Mareks Disease,Newcastle Disease,Infectious Bursal Disease,Infectious Bronchitis,Others),and Geography  

Purchase Option

$ 3100
$ 4600
$ 6900

Latin America Poultry Vaccines Market size was at valued US$ XX Mn in 2023 and poised to grow at significant CAGR of x% over 2024-2030. Vaccines are biological preparations that provide acquired immunity to particular disease in human beings or animals. Poultry vaccines are used to prevent or cure the various diseases in poultry such as Mareks disease, Newcastle disease, and infectious diseases among others. Rise in population demand for healthy meat and poultry products, increase in adoption newer poultry vaccines, government initiations to protect the animal health and increase the poultry production, and increase in the number of poultry farms are expected boost the Latin America poultry vaccines market over the forecast period. However, stringent regulatory guidelines for vaccine approvals, lack of awareness about the poultry vaccination in underdeveloped countries, adverse effects associated with vaccines and high cost of vaccines may hamper the growth of Latin America poultry vaccines market in future years.

 

Latin America Poultry Vaccines Market Dynamics

Government efforts, fast increase of the poultry population, rising prevalence of zoonotic illnesses, technical advancements, and rising demand for poultry-derived food items and poultry vaccination are the primary drivers driving the global poultry vaccines market forward.

Key Features of the Reports

  • The latin america poultry vaccines market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Latin America Poultry Vaccines Market Segmentation

By Vaccine type
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
By Formulation
  • Dry Form (Duct) Vaccines
  • Liquid Vaccines
  • Freeze Dried Vaccines
By Application
  • Mareks Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Others

Frequently Asked Questions

The Latin America Poultry Vaccines Market Market size was at valued US$ XX Mn in 2023 and poised to grow at significant CAGR of x% over 2024-2030.

The Latin America Poultry Vaccines Market data: Latin America (Brazil, Mexico, Argentina)

The Latin America Poultry Vaccines Market Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Phibro Animal health Corporation (U.S.), Zydus AHL (India), Ceva Sante Animale (France)

1.Executive Summary
2. Latin America Poultry Vaccines Market Introduction 
2.1. Latin America Poultry Vaccines Market  - Taxonomy
2.2. Latin America Poultry Vaccines Market  - Definitions
2.2.1.Vaccine type
2.2.2.Formulation
2.2.3.Application
2.2.4.Country
3. Latin America Poultry Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Latin America Poultry Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Latin America Poultry Vaccines Market  By Vaccine type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Live Attenuated Vaccines
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Recombinant Vaccines
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Latin America Poultry Vaccines Market  By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Dry Form (Duct) Vaccines
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Liquid Vaccines
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Freeze Dried Vaccines
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Latin America Poultry Vaccines Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Mareks Disease
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Newcastle Disease
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Infectious Bursal Disease
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Infectious Bronchitis
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Latin America Poultry Vaccines Market  By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Brazil
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Mexico
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Argentina
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Venezuela
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Rest of Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. Competition Landscape
9.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
9.2.1.Zoetis (Pfizer, Inc.) (U.S.)
9.2.2.Merck & Co. Inc. (U.S)
9.2.3.Boehringer Ingelheim Vetmedica (Germany)
9.2.4.Elanco (U.S.)
9.2.5.Bayer Animal Health (Germany)
9.2.6.Ceva Sante Animale (France)
9.2.7.Zydus AHL (India)
9.2.8.Hester Biosciences Limited. (India)
9.2.9.Biovet (Brazil)
10. Research Methodology 
11. Appendix and Abbreviations 
  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Zydus AHL (India)
  • Hester Biosciences Limited. (India)
  • Biovet (Brazil)

Adjacent Markets